Dr. Menalee K. Hapuarachchi, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 8
- In the NPI registry since
- 2018
- Medicare patients seen, 2024
- 70
Licensed in Texas since 2022, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2018Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
TX license T5919 (first issued 2022; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Texas Health Arlington Memorial Hospital Arlington, TX
Medical groups
- Texas Digestive Disease Consultants, PLLC (608 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 70
- Services billed
- 1,267
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Arlington, TX | 21 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Arlington, TX | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 37 payments worth $742 in total to this clinician.
| AbbVie Inc. | $154 |
|---|---|
| Janssen Biotech, Inc. | $93.43 |
| Ipsen Biopharmaceuticals, Inc | $86.08 |
| Takeda Pharmaceuticals U.S.A., Inc. | $59.79 |
| Madrigal Pharmaceuticals | $45.80 |
| Celltrion USA Inc. | $45.24 |
| Ardelyx, Inc. | $44.41 |
| Lilly USA, LLC | $40.28 |
| Food and Beverage | $733 |
|---|---|
| Education | $9.65 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Oct 21, 2025 | Education SKYRIZI · IMMUNOLOGY · in-kind | $9.65 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.